- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BioLife Solutions Inc (BLFS)
BioLife Solutions Inc stock price live, this page displays NASDAQ BLFS stock exchange data. View the BLFS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BioLife Solutions Inc real time stock price chart below.
What Is the BioLife Solutions Inc Stock Price Today?
The BioLife Solutions Inc stock price today is 24.87.
What Is the Stock Symbol for BioLife Solutions Inc?
The stock symbol for BioLife Solutions Inc is "BLFS."
What Stock Exchange Does BioLife Solutions Inc Trade On?
BioLife Solutions Inc is listed and trades on the NASDAQ stock exchange.
Is BioLife Solutions Inc a Good Stock to Buy?
Determining whether BioLife Solutions Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BLFS quote. (ISIN: US09062W2044)
What Is the BioLife Solutions Inc Stock Price Today?
The BioLife Solutions Inc stock price today is 24.87.
What Is the Stock Symbol for BioLife Solutions Inc?
The stock symbol for BioLife Solutions Inc is "BLFS."
What Stock Exchange Does BioLife Solutions Inc Trade On?
BioLife Solutions Inc is listed and trades on the NASDAQ stock exchange.
Is BioLife Solutions Inc a Good Stock to Buy?
Determining whether BioLife Solutions Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BLFS quote. (ISIN: US09062W2044)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.63
25.94
52 wk Range
19.10
29.62
BLFS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.6325.94
52 wk Range
19.1029.62
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BLFS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
32.44
Upside
+30.46%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price movements are quite volatile
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
BioLife Solutions Inc Company Profile
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
BioLife Solutions Inc Earnings Call Summary for Q3/2025
- BioLife Solutions reported Q3 2025 revenue of $28.1M (31% YoY growth), exceeding forecasts of $25.69M, with EPS of $0.01 versus expected loss of $0.01
- Cell processing revenue reached $25.4M (up 33% YoY) with adjusted EBITDA of $7.8M (28% of revenue) and GAAP gross margin of 62%
- Company completed strategic divestiture of Evo Cold Chain Logistics for $25.5M while maintaining market leadership in biopreservation media
- Management projects 2025 total revenue between $95-96M (27-29% growth) with planned price increases of 4-6% for 2026
- Despite positive results, stock declined 1.99% in aftermarket trading to $27.57, remaining near its 52-week high of $29.62
Last Updated: 2025-11-06, 05:36 p/m
Read Full TranscriptCompare BLFS to Peers and Sector
Metrics to compare | BLFS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBLFSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −67.2x | −7.1x | −0.6x | |
PEG Ratio | −0.72 | −0.01 | 0.00 | |
Price/Book | 3.4x | 1.6x | 2.6x | |
Price / LTM Sales | 12.0x | 2.9x | 3.4x | |
Upside (Analyst Target) | 32.7% | 11.8% | 42.0% | |
Fair Value Upside | Unlock | 8.0% | 5.0% | Unlock |
Analyst Ratings
10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 32.44
(+30.46% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
0.01 / -0.01
Revenue / Forecast
28.07M / 25.69M
People Also Watch
FAQ
What Is the BioLife Solutions (BLFS) Stock Price Today?
The BioLife Solutions stock price today is 24.87
What Stock Exchange Does BioLife Solutions Trade On?
BioLife Solutions is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for BioLife Solutions?
The stock symbol for BioLife Solutions is "BLFS."
What Is the BioLife Solutions Market Cap?
As of today, BioLife Solutions market cap is 1.20B.
What Is BioLife Solutions's Earnings Per Share (TTM)?
The BioLife Solutions EPS (TTM) is -0.38.
When Is the Next BioLife Solutions Earnings Date?
BioLife Solutions will release its next earnings report on Mar 12, 2026.
From a Technical Analysis Perspective, Is BLFS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has BioLife Solutions Stock Split?
BioLife Solutions has split 2 times.
How Many Employees Does BioLife Solutions Have?
BioLife Solutions has 159 employees.
What is the current trading status of BioLife Solutions (BLFS)?
As of Jan 24, 2026, BioLife Solutions (BLFS) is trading at a price of 24.87, with a previous close of 25.98. The stock has fluctuated within a day range of 24.63 to 25.94, while its 52-week range spans from 19.10 to 29.62.
What Is BioLife Solutions (BLFS) Price Target According to Analysts?
The average 12-month price target for BioLife Solutions is USD32.44, with a high estimate of USD34 and a low estimate of USD30. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +30.46% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.